Report - Biomarkers and surrogate endpoints: How and when might they impact drug development? · 2019. 8. 1. · development? Chetan D. Lathia Clinical Pharmacology, Bayer Corporation, West

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form